trial

Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT

NCTId NCT05766540
as of 2026-07-01
at a glance
Phase 4 · Unknown
Enrollment 60 (estimated)
Primary completion 2023-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Unknown
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2023-08-20
Primary completion
2023-11-30
Eligibility
ALL · 25 Years · 80 Years

Interventions & indications

Sponsors

Sites

0 total

Facts & assertions

4 sourced
Enrollment
60
Phase
PHASE4
Primary Completion Date
2023-11-30
Status
UNKNOWN